Canntab Therapeutics Limited (CTABF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.84 Million | -2.84 Million | -1.89 Million | -2.33 Million | -1.26 Million | -354.8 Thousand |
| Net Income | -3.68 Million | -4.41 Million | -2.6 Million | -2.45 Million | -2.4 Million | -1.11 Million |
| Depreciation & Amortization | 634.71 Thousand | 546.34 Thousand | 295.61 Thousand | 80.6 Thousand | 51.48 Thousand | 1615.00 |
| Deferred income taxes | -474.83 Thousand | 900.3 Thousand | - | - | - | - |
| Stock-based compensation | 450.34 Thousand | 632.77 Thousand | 414.75 Thousand | 402.36 Thousand | - | 681.6 Thousand |
| Change in working capital | -182.44 Thousand | -647.38 Thousand | 130.78 Thousand | -317.45 Thousand | 107.95 Thousand | 78.23 Thousand |
| Other non-cash items | 415.5 Thousand | 138.27 Thousand | -133.33 Thousand | -39.99 Thousand | 660.29 Thousand | - |
| Investing Cash Flow | 151.35 Thousand | -345.08 Thousand | 269.67 Thousand | 2 Million | -199.06 Thousand | -99.57 Thousand |
| Investments in PPE | -88.13 Thousand | -345.08 Thousand | -905.33 Thousand | -317.71 Thousand | -199.06 Thousand | -99.57 Thousand |
| Acquisitions | 239.48 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 1.17 Million | 2.32 Million | - | - |
| Other Investing Activities | 239.48 Thousand | -73.13 Thousand | 1.07 Million | - | - | - |
| Financing Cash Flow | 1.89 Million | 2.59 Million | 3.3 Million | 21.9 Thousand | 4.72 Million | 1.41 Million |
| Debt repayment | -63.88 Thousand | -78.53 Thousand | -65.16 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 658.86 Thousand | 813.75 Thousand | 3.64 Million | 21.9 Thousand | 5 Million | 1.41 Million |
| Other Financing Activities | 1.95 Million | 1.85 Million | -272.12 Thousand | 21.9 Thousand | -280.61 Thousand | - |
| Accounts receivables | -2357.00 | -59.85 Thousand | 88.42 Thousand | -69.74 Thousand | -129.32 Thousand | 19.51 Thousand |
| Accounts payables | -202 Thousand | 206.59 Thousand | 908.12 Thousand | -81.26 Thousand | - | - |
| Inventory | 499.00 | -878.9 Thousand | -905.76 Thousand | -166.66 Thousand | - | - |
| Other working capital | 21.41 Thousand | 84.78 Thousand | 40 Thousand | 214.00 | 237.27 Thousand | 58.72 Thousand |
| Cash at beginning of period | 1.49 Million | 2.09 Million | 413.97 Thousand | 717.85 Thousand | 958.62 Thousand | - |
| Cash at end of period | 691.11 Thousand | 1.49 Million | 2.09 Million | 413.97 Thousand | 4.21 Million | 958.62 Thousand |
| Capital Expenditure | -88.13 Thousand | -345.08 Thousand | -905.33 Thousand | -317.71 Thousand | -199.06 Thousand | -99.57 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -799.75 Thousand | -599.57 Thousand | 1.67 Million | -303.87 Thousand | 3.25 Million | 958.62 Thousand |
| Free Cash Flow | -2.93 Million | -3.19 Million | -2.8 Million | -2.65 Million | -1.46 Million | -454.38 Thousand |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -412.62 Thousand | -1.03 Million | -467.8 Thousand | -3.68 Million | -1.44 Million | -418.33 Thousand |
| Depreciation & Amortization | 91.5 Thousand | 171.72 Thousand | 139 Thousand | 634.71 Thousand | 188.57 Thousand | 109.08 Thousand |
| Deferred income taxes | - | 291.8 Thousand | -293.55 Thousand | -474.83 Thousand | 280.34 Thousand | -488.6 Thousand |
| Stock-based compensation | - | 16.32 Thousand | 46.4 Thousand | 450.34 Thousand | - | 96.11 Thousand |
| Change in working capital | 57.04 Thousand | 259.04 Thousand | -156.99 Thousand | -182.44 Thousand | -45.64 Thousand | -163.21 Thousand |
| Other non-cash items | 226.38 Thousand | 234.56 Thousand | 205.9 Thousand | 415.5 Thousand | 164.37 Thousand | -383.44 Thousand |
| Investing Cash Flow | -2781.00 | -12.39 Thousand | - | 151.35 Thousand | -13.21 Thousand | 218.86 Thousand |
| Investments in PPE | -2781.00 | -12.39 Thousand | - | -88.13 Thousand | -13.21 Thousand | -20.62 Thousand |
| Acquisitions | - | - | - | 239.48 Thousand | - | 239.48 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.78 | -12.39 | - | 239.48 Thousand | - | 218.53 Thousand |
| Financing Cash Flow | 1967.00 | -20.13 Thousand | -18.9 Thousand | 1.89 Million | -17.7 Thousand | 1.71 Million |
| Debt repayment | -1967.00 | -20.13 Thousand | -18.9 Thousand | -63.88 Thousand | -17.7 Thousand | -16.52 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 658.86 Thousand | - | 427.11 Thousand |
| Other Financing Activities | 1967.00 | -20.13 Thousand | -18.9 Thousand | 1.95 Million | -17.7 Thousand | 1.72 Million |
| Accounts receivables | -12.1 Thousand | 226.47 Thousand | -36.69 Thousand | -2357.00 | -10.46 Thousand | -140.93 Thousand |
| Accounts payables | 84.06 Thousand | -22.33 Thousand | -77.54 Thousand | -202 Thousand | -89 Thousand | 53.55 Thousand |
| Inventory | -17.46 Thousand | 16.65 Thousand | -51.05 Thousand | 499.00 | 67.71 Thousand | -83.33 Thousand |
| Other working capital | 2553.00 | 38.25 Thousand | 8303.00 | 21.41 Thousand | -13.88 Thousand | 61.06 Thousand |
| Cash at beginning of period | 55.31 Thousand | 145.16 Thousand | 691.11 Thousand | 1.49 Million | 1.5 Million | 331.74 Thousand |
| Cash at end of period | 16.81 Thousand | 55.31 Thousand | 145.16 Thousand | 691.11 Thousand | 691.11 Thousand | 1.5 Million |
| Capital Expenditure | -2781.00 | -12.39 Thousand | - | -88.13 Thousand | -13.21 Thousand | -20.62 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -38.5 Thousand | -89.85 Thousand | -545.94 Thousand | -799.75 Thousand | -810.1 Thousand | 1.16 Million |
| Free Cash Flow | -40.46 Thousand | -69.71 Thousand | -527.03 Thousand | -2.93 Million | -792.4 Thousand | -780.41 Thousand |
GCOM
LTRYW
STP
LTFD
PRSI
AQQSQ